ACTR2, a component of the actin-related protein complex that governs actin nucleation, was targeted by miR-30a-5p and miR-335-3p, suggesting that these miRNAs could influence axonal remodeling and synaptic structure, processes that are often impaired in diseases such as AD and PD [71,72]. This evidence concerns the gene ACTR2 and Parkinson disease.